Alydia Health is a medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage.
Alydia Health is a medical device company working toward a solution to postpartum hemorrhage (PPH), the number one cause of maternal death. Their single-minded focus is to improve radically the treatment path for postpartum hemorrhage from the traumatic, life-altering condition that it is today. They are devoted to improving the lives of women around the world.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 30, 2020 | Series C | $13.90M | 3 | AXA Investment Managers | — | Detail |
Aug 28, 2018 | Series B | $10.27M | 3 | Global Health Investment Fund (GHIF) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
AXA Investment Managers | Yes | Series C |
Avestria Ventures | — | Series C |
Global Health Investment Fund (GHIF) | — | Series C |
Astia Angels | — | Series B |
Kimberly Vogel | — | Series B |